SRL Diagnostics revenue surpasses Rs 1,000 crore mark

Published On 2018-01-04 07:00 GMT   |   Update On 2018-01-04 07:00 GMT

New Delhi: SRL Diagnostics (SRL) announced that it has become the first Indian diagnostics company to surpass Rs 1,000 cr revenue in the calendar year 2017.


This milestone achievement positions SRL as the largest diagnostics company in the country by revenue.


SRL Diagnostics, established in 1995, has been on the forefront, constantly delivering quality diagnostics to its customers. In the past over two decades of the company’s journey, SRL has grown into a ‘Full-Service Diagnostics’ player striving for excellence in every service offered.


Today SRL touches the lives of over 1.5 cr patients annually in 600 cities across 30 states in India. SRL has partnered with the government (under Public Private Partnership) in 3 states – Jharkhand, Himachal Pradesh, and Uttar Pradesh. These associations have enabled SRL in catering to the masses by providing them with quality healthcare services. SRL is also the preferred and chosen lab partner for UNICEF’s Comprehensive National Nutrition Survey, CNNS, which is first of its kind in the country.


On this landmark achievement of Rs. 1,000 cr revenue, Mr. Arindam Haldar, CEO, SRL Diagnostics said, “Great companies are innovative and customer-centric. But the best of them combine innovation with superior execution. SRL has today evolved into India’s largest and preferred diagnostics chain with an impressive reach, relentlessly operating from a paradigm of quality and customer first. This achievement is a recognition of SRL constantly delivering on its promise of excellence with quality”. He further stated, “I would like to express my gratitude to all our customers, partners, employees and other stakeholders for reposing trust on us and standing shoulder-to-shoulder to provide the best services.”

Article Source : Press Release

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News